• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板中花生四烯酸转化途径中的人类补体。

Human complement in the arachidonic acid transformation pathway in platelets.

作者信息

Polley M J, Nachman R L, Weksler B B

出版信息

J Exp Med. 1981 Feb 1;153(2):257-68. doi: 10.1084/jem.153.2.257.

DOI:10.1084/jem.153.2.257
PMID:7241047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2186082/
Abstract

Arachidonate-mediated release of 14C serotonin and thromboxane B2 (TXB2) is significantly enhanced in the presence of complement. Only purified complement components C5, C6, C7, C8, and C9 are required for this reactivity. No known activating mechanism of the classical or alternative pathway is required, nor is C3. In the absence of exogenously added complement, platelet membrane-bound complement components play an essential role in modulating arachidonate-mediated serotonin release. Incubation of platelet membranes with arachidonate and C5--C9 led to the production of dimers of the membrane attack complex (C5b--9) on the platelet surface. These macromolecular complexes were eluted from the platelet membrane and were identified physicochemically and morphologically. The possibility arises that C3 in association with C5--C9 is required for mobilization of the arachidonic acid from the phospholipid of the platelet membrane. Once the arachidonic acid is mobilized, C3 is no longer required, C5--C9 being sufficient to modulate this pathway leading to enhanced production of TXB2.

摘要

在补体存在的情况下,花生四烯酸介导的14C血清素和血栓素B2(TXB2)释放显著增强。这种反应性仅需要纯化的补体成分C5、C6、C7、C8和C9。不需要经典途径或替代途径的已知激活机制,也不需要C3。在没有外源添加补体的情况下,血小板膜结合的补体成分在调节花生四烯酸介导的血清素释放中起重要作用。用花生四烯酸和C5 - C9孵育血小板膜导致血小板表面形成膜攻击复合物(C5b - 9)的二聚体。这些大分子复合物从血小板膜上洗脱下来,并通过物理化学和形态学方法进行鉴定。有可能C3与C5 - C9结合是从血小板膜磷脂中动员花生四烯酸所必需的。一旦花生四烯酸被动员,就不再需要C3,C5 - C9足以调节该途径,导致TXB2产生增加。

相似文献

1
Human complement in the arachidonic acid transformation pathway in platelets.血小板中花生四烯酸转化途径中的人类补体。
J Exp Med. 1981 Feb 1;153(2):257-68. doi: 10.1084/jem.153.2.257.
2
Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.凝血酶介导的血小板功能中的人补体:C5b-9复合物的摄取
J Exp Med. 1979 Sep 19;150(3):633-45. doi: 10.1084/jem.150.3.633.
3
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.细菌对补体介导杀伤作用的抗性机制研究。VI. IgG通过在C5裂解前的一个步骤发挥作用,提高C5b-9对大肠杆菌0111B4的杀菌效率。
J Immunol. 1983 Nov;131(5):2570-5.
4
Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9.晚期补体成分C5b-9诱导人血小板中血栓素B2的合成。
Int Arch Allergy Appl Immunol. 1987;82(3-4):313-6. doi: 10.1159/000234215.
5
Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components.巨噬细胞会响应补体晚期成分而释放花生四烯酸、前列腺素E2和血栓素。
J Immunol. 1984 Oct;133(4):2145-50.
6
Secretion of the terminal complement proteins, C5-C9, by human platelets.人血小板分泌末端补体蛋白C5 - C9。
Clin Immunol Immunopathol. 1989 Mar;50(3):385-93. doi: 10.1016/0090-1229(89)90145-1.
7
Human platelet-initiated formation and uptake of the C5-9 complex of human complement.人血小板启动人补体C5-9复合物的形成与摄取。
J Clin Invest. 1976 Jan;57(1):203-11. doi: 10.1172/JCI108261.
8
Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.细菌对补体介导杀伤作用的抗性机制研究。I. 末端补体成分沉积于明尼苏达沙门氏菌S218并从该菌释放,但未导致细菌死亡。
J Exp Med. 1982 Mar 1;155(3):797-808. doi: 10.1084/jem.155.3.797.
9
C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.不依赖C3的免疫溶血:在无C3参与的情况下,C5 - C9对EAC14oxy2细胞的溶血作用
Immunology. 1984 Nov;53(3):575-82.
10
Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.细菌对补体介导杀伤的抗性机制研究。II. C8和C9从明尼苏达沙门氏菌S218表面释放C5b67,因为末端复合物不能插入细菌外膜。
J Exp Med. 1982 Mar 1;155(3):809-19. doi: 10.1084/jem.155.3.809.

引用本文的文献

1
Eculizumab treatment alters the proteometabolome beyond the inhibition of complement.依库珠单抗治疗除了抑制补体之外还会改变蛋白质组代谢组。
JCI Insight. 2023 Jul 10;8(13):e169135. doi: 10.1172/jci.insight.169135.
2
Genome-wide association studies of 74 plasma metabolites of German shepherd dogs reveal two metabolites associated with genes encoding their enzymes.全基因组关联研究发现德国牧羊犬 74 种血浆代谢物中的两种代谢物与编码其酶的基因有关。
Metabolomics. 2019 Sep 6;15(9):123. doi: 10.1007/s11306-019-1586-2.
3
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).鉴定补体在受刺激血小板上通过备解素和 C3(H2O)介导的新型激活方式。
J Immunol. 2013 Jun 15;190(12):6457-67. doi: 10.4049/jimmunol.1300610. Epub 2013 May 15.
4
Human platelet activation by C3a and C3a des-arg.C3a和C3a去精氨酸对人血小板的激活作用
J Exp Med. 1983 Aug 1;158(2):603-15. doi: 10.1084/jem.158.2.603.
5
Inflammatory mediators released by complement-derived peptides.补体衍生肽释放的炎症介质。
Agents Actions. 1983 Aug;13(5-6):405-14. doi: 10.1007/BF02176403.
6
Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives.补体对细胞膜攻击的后果:花生四烯酸的释放及炎症衍生物的形成。
Proc Natl Acad Sci U S A. 1983 Nov;80(21):6647-51. doi: 10.1073/pnas.80.21.6647.
7
Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures.人单核细胞的花生四烯酸代谢。血小板去除培养物的研究。
J Exp Med. 1983 Aug 1;158(2):393-412. doi: 10.1084/jem.158.2.393.
8
Relationships among the complement, kinin, coagulation, and fibrinolytic systems.补体、激肽、凝血和纤溶系统之间的关系。
Springer Semin Immunopathol. 1983;6(2-3):231-58. doi: 10.1007/BF00205875.
9
Functional C8 associated with human platelets.与人类血小板相关的功能性C8。
Clin Exp Immunol. 1986 Nov;66(2):472-80.
10
Studies of progressive glomerular sclerosis in the rat.大鼠进行性肾小球硬化的研究。
Am J Pathol. 1986 Jun;123(3):553-62.

本文引用的文献

1
Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.通过二硫键还原从二价兔抗体分子中分离单价片段。
Arch Biochem Biophys. 1960 Aug;89:230-44. doi: 10.1016/0003-9861(60)90049-7.
2
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
3
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.人补体第四成分的分离与描述
J Exp Med. 1963 Sep 1;118(3):447-66. doi: 10.1084/jem.118.3.447.
4
Conjugation of antibody to ferritin by means of p,p'-difluoro-m, m'-dinitrodiphenylsulphone.通过对,对'-二氟-间,间'-二硝基二苯砜将抗体与铁蛋白结合。
Arch Biochem Biophys. 1962 May;97:429-30. doi: 10.1016/0003-9861(62)90102-9.
5
A new supporting medium for preparative electrophoresis.一种用于制备电泳的新型支持介质。
Scand J Clin Lab Invest. 1960;12:33-7.
6
Lactic dehydrogenase activity in blood.血液中的乳酸脱氢酶活性。
Proc Soc Exp Biol Med. 1955 Oct;90(1):210-3. doi: 10.3181/00379727-90-21985.
7
The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.人类补体的第八成分(C8):分离、特性鉴定及溶血效率
J Exp Med. 1969 Nov 1;130(5):1145-60. doi: 10.1084/jem.130.5.1145.
8
Effect of temperature and inhibitors on serotonin-14C release from human platelets.温度和抑制剂对人血小板中5-羟色胺-14C释放的影响。
Am J Physiol. 1971 Jan;220(1):105-11. doi: 10.1152/ajplegacy.1971.220.1.105.
9
Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.关于人补体成分5的进一步研究:改进纯化方法的开发以及通过聚丙烯酰胺凝胶电泳对纯化产物进行表征
Immunochemistry. 1972 Jul;9(7):709-23. doi: 10.1016/0019-2791(72)90015-8.
10
The ninth component of human complement: isolation, description and mode of action.人类补体的第九个成分:分离、描述及作用方式
Immunology. 1969 Jun;16(6):719-35.